
Emboline Announces First One Hundred Patients Treated in IDE Study of Emboliner® to Minimize Stroke Risk From TAVR prn.to/43gR8ev
prn.toEmboline Announces That the First One Hundred Patients Have Been Treated in the IDE Study of the.../PRNewswire/ -- Emboline, Inc., a privately held medical technology company focused on reducing stroke and ischemic damage during structural heart procedures...
